IXION BIOTECHNOLOGY INC has a total of 23 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are ONCOGENEX TECHNOLOGIES INC, FU YU-SHOW and CSL BEHRING GENE THERAPY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 4 | |
#4 | Australia | 3 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Foods | |
#5 | Measuring microorganism processes | |
#6 | Animal care | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Sidhu Harmeet | 10 |
#2 | Ramiya Vijayakumar K | 6 |
#3 | Allison Milton J | 6 |
#4 | Clark Amy | 4 |
#5 | Yin Li | 3 |
#6 | Peck Ammon B | 3 |
#7 | Ramiya Vijaykumar | 2 |
#8 | Ramiya Vijayakumar | 1 |
#9 | Cornelius Janet | 1 |
#10 | Clark Amy M | 1 |
Publication | Filing date | Title |
---|---|---|
WO2004087885A2 | Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway | |
EP1444345A1 | Conversion of liver stem and progenitor cells to pancreatic functional cells | |
AU2002363783A1 | Materials and methods for reducing oxalate concentrations in fluids | |
WO02079457A1 | Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway | |
US6355242B1 | Materials and methods for treating or preventing oxalate-related disease | |
US6703017B1 | Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures | |
AU1453299A | Materials and methods for quantitative pcr | |
AU7590798A | Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease |